{"nct_id":"NCT05933070","title":"A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2020-06-15","start_date_type":"ACTUAL","primary_completion_date":"2024-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["INMB"]}